| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.085 | 0.07 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.097 | 0.07 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.07 | 0.07 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.07 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.072 | 0.07 |